×

BRIEF-GW Pharma Sativex study shows MS spasticity benefits

LONDON, Oct 12 (Reuters) - GW Pharmaceuticals PLC :

* Positive German sativex data presented at ectrims

* confirms clinically relevant benefits in Multiple Sclerosis Spasticity

((London Equities Newsroom; +44 20 7542 7717))

((For more news, please click here ))